Delhi High Court allows Dr Reddy’s to export Ozempic-like drug
after close1 source ↓written by the desknot a recommendation
The Delhi High Court upheld an order permitting Dr Reddy’s Laboratories to manufacture and export a drug similar to Ozempic. This decision follows a challenge by Novo Nordisk, which argued that the production infringes its patent rights. The court noted that the ruling only allows export, not domestic sale, indicating a significant development for Dr Reddy's in the global market.
Not investment advice. For informational purposes only.